LMC | Manna Research Capabilities Include:

Did you know?
• 19 sites across 4 provinces with 20+ years research experience as operations started in 1996
• >1600 clinical trials conducted
• Comprehensive patient database – >500,000 patients with addition of 50,000 new patients per year
• Access to a network of 80 Family Physicians & 75 Specialists with focus in Endocrine Disorders
• Phase I – 12 bed clinical pharmacology unit in Greater Toronto Area (4th largest city in North America)
• Voted one of Canada’s Best Work Places in 2014 & 2015
• Consistent leaders in Canadian & Global enrollment
• Able to work with central Ethics Review Boards

LMC Research

Cardiovascular
Chronic Kidney Disease
Diabetes
Lipids
NASH
Obesity

Manna Research

Cardiology
Dermatology
Endocrinology
Gastroenterology
Gynecology
Immunology / Infectious Disease – Vaccines
Musculoskeletal
Psychiatry/Psychology
Pulmonary/Respiratory
Rheumatology
Urology
Women’s & Men’s Health

PHASE I

  • 12 Metabolic Beds
  • Glucose Clamping
  • Metabolic Kitchen
  • Access to Primary Care Patients

PHASE II – III

  • 19 Sites Across Canada
  • 50 Endocrinologists
  • Access to 80 GP’s and 75 Specialists with focus in Endocrine Disorders
  • Canada’s Largest Diabetes & Obesity Patient Registries
  • Comprehensive patient database – >500,000 patients with addition of 50,000 new patients per year

PHASE IV

  • Post- Marketing Analysis
  • Registry Analysis
  • Compliance Programs

Centralized Research Network

  • < 2-week Health Canada approvals
  • Central Ethics capability
  • CTA / Budget with < 5-day average turnaround
  • < 2-week Start-Up timelines
  • Regulatory Affairs with Start-Up Specialists
  • One point of contact – feasibilities@LMCManna.com

Patient-Centric

  • COVID-19 Pre-screening prior to visit
  • 100% telemedicine & virtual visits capability
  • Direct-to-Patient (DTP) care (home visits) as needed
  • Full Recruitment & Marketing Team – Call Centre
  • E-consent capability
  • Patient Advisory Group access

Extended Services

  • Full Service CRO support as needed
  • Phase 1-4 capabilities
  • Local Labs – PBMC available
  • Access to COVID testing – viral or immunity
  • Quality Management Systems
  • Community & Patient Partnerships

Membership & Distinctions

  • Part of Sanofi’s “Diabetes Centers of Excellence” Network
  • Canadian Association of Independent Clinical Research (CAICR) Membership
  • Society for Clinical Research Sites (SCRS) Membership
  • PharmaTimes Clinical Research Coordinator of the Year 2017 (CROY 2017)
  • Site Patient Recruitment Innovation Award (SPRIA) 2017 Winner

LMC | Manna Research Highlights

  • Efficient Start Up – 33 First patient visit (FPFV) entered into trial for Canada since 2013,with 13 FPFV in 2016 alone
  • >4000 patient randomizations since 2013 across all sites in Canada
  • Global leaders in enrollment – possibility of using one network to enroll entire country patient allocation
  • Internal Quality Assurance & Quality Control Program – Successful FDA, Health Canada & Sponsor audits
  • Benefits of research in Canada: high quality, speed (30 day regulatory approval), & value (due to exchange rate)

EXCITED TO LEARN MORE?